Pay in 4 interest-free payments of $6.64 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Several macro and micro-level drivers are driving this obesity care revolution: Rising Prevalence : By 2030, nearly half the worlds population will be living with overweight or obesity, an alarming epidemiological trend that brings public health systems to a tipping point
Mahzari MM, Alluhayyan OB, Almutairi MH, Bayounis MA, Alrayani YH, Omair AA, et al
Payer partnerships and pharmacy-bundled models are included when they support a licensed care pathway
Large cardiovascular outcome trials involving tens of thousands of patientssuch as LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide)have not demonstrated an increased incidence of medullary thyroid carcinoma or other thyroid malignancies compared to placebo groups
Another study found that treatment with metformin can regulate the immune response in the intestines of mice by altering the composition of the gut microbiome, particularly through the downregulation of the NF-B signaling pathway (Brvba et al., 2023)
US$ 21.73
,aspect=ignore)
US$ 28.27
US$ 28.12
US$ 24.63
